Cognition Therapeutics, Inc. (CGTX) Operating cash flow 2020–2025
Cognition Therapeutics, Inc. (CGTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2020: -$3.4M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +13.6% |
| FY2024 | -$28.5M | -77.8% |
| FY2023 | -$16.0M | +13.6% |
| FY2022 | -$18.5M | -410.4% |
| FY2021 | -$3.6M | -5.8% |
| FY2020 | -$3.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice